Scn2a^em1Kea

CRISPR/Cas9 editing was used to introduce a single nucleotide change AAA to GAA, resulting in substitution of glutamate for lysine at position 1422 (K1422E). This corresponds to the neurodevelopmental disorder-associated p.K1422E pathogenic variant in humans. (J:334960)